211 related articles for article (PubMed ID: 37762600)
21. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.
Yang R; Xing L; Zheng X; Sun Y; Wang X; Chen J
Mol Cancer; 2019 Jan; 18(1):4. PubMed ID: 30621700
[TBL] [Abstract][Full Text] [Related]
22. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
[TBL] [Abstract][Full Text] [Related]
23. MiR-1976 knockdown promotes epithelial-mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis.
Wang J; Li M; Han X; Wang H; Wang X; Ma G; Xia T; Wang S
Cell Death Dis; 2020 Jul; 11(7):500. PubMed ID: 32620748
[TBL] [Abstract][Full Text] [Related]
24. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
Han C; Fu Y; Zeng N; Yin J; Li Q
Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
[TBL] [Abstract][Full Text] [Related]
25. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
[TBL] [Abstract][Full Text] [Related]
26. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer.
Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806
[TBL] [Abstract][Full Text] [Related]
27. miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
Lv ZD; Kong B; Liu XP; Jin LY; Dong Q; Li FN; Wang HB
J Cell Mol Med; 2016 May; 20(5):864-73. PubMed ID: 26820102
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-1246 suppresses the metastasis of breast cancer cells by targeting the DYRK1A/PGRN axis to prevent the epithelial-mesenchymal transition.
Wang P; Chen W; Zhang Y; Zhong Q; Li Z; Wang Y
Mol Biol Rep; 2022 Apr; 49(4):2711-2721. PubMed ID: 35059968
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-543 inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition of triple-negative breast cancer cells via down-regulation of ACTL6A gene.
Wang YL; Liang RH; Wang CY; Zhang RP; Wu SY; Han X; Zhang GL
Clin Transl Oncol; 2022 Jan; 24(1):84-92. PubMed ID: 34181232
[TBL] [Abstract][Full Text] [Related]
30. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator.
Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q
Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250
[TBL] [Abstract][Full Text] [Related]
32. TFAP2A downregulation mediates tumor-suppressive effect of miR-8072 in triple-negative breast cancer via inhibiting SNAI1 transcription.
Fang Y; Wang Y; Ma H; Guo Y; Xu R; Chen X; Chen X; Lv Y; Li P; Gao Y
Breast Cancer Res; 2024 Jun; 26(1):103. PubMed ID: 38890750
[TBL] [Abstract][Full Text] [Related]
33. MiR-140-5p inhibits cell proliferation and metastasis by regulating MUC1 via BCL2A1/MAPK pathway in triple negative breast cancer.
Yu B; You W; Chen G; Yu Y; Yang Q
Cell Cycle; 2019 Oct; 18(20):2641-2650. PubMed ID: 31411515
[TBL] [Abstract][Full Text] [Related]
34. MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib.
Jonas K; Prinz F; Ferracin M; Krajina K; Pasculli B; Deutsch A; Madl T; Rinner B; Slaby O; Klec C; Pichler M
Breast Cancer Res; 2023 Oct; 25(1):119. PubMed ID: 37803350
[TBL] [Abstract][Full Text] [Related]
35. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
Ji H; Sang M; Liu F; Ai N; Geng C
Pathol Res Pract; 2019 Apr; 215(4):697-704. PubMed ID: 30611621
[TBL] [Abstract][Full Text] [Related]
36. miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer.
Yan M; Li X; Tong D; Han C; Zhao R; He Y; Jin X
Oncol Rep; 2016 Jul; 36(1):65-71. PubMed ID: 27108696
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.
Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X
Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958
[TBL] [Abstract][Full Text] [Related]
38. miR-5590-3p-YY1 feedback loop promotes the proliferation and migration of triple-negative breast cancer cells.
Liang F; Fu X; Wang L
J Cell Biochem; 2019 Oct; 120(10):18415-18424. PubMed ID: 31190375
[TBL] [Abstract][Full Text] [Related]
39. Down-Regulation of miR-194-5p for Predicting Metastasis in Breast Cancer Cells.
Yen YT; Yang JC; Chang JB; Tsai SC
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008751
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of MGP by HOXC8 promotes the proliferation, migration, and EMT processes of triple-negative breast cancer.
Gong C; Zou J; Zhang M; Zhang J; Xu S; Zhu S; Yang M; Li D; Wang Y; Shi J; Li Y
Mol Carcinog; 2019 Oct; 58(10):1863-1875. PubMed ID: 31264274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
